| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.0063 |
0.9 |